Angelini Pharma to acquire Catalyst Pharmaceuticals for equity value of $4.1bn Pharmaceutical Technology 1d
Family-Run Angelini Pharma Buys Catalyst Pharmaceuticals For Over 4 Billion Benzinga 2d Article paywall
Hantavirus outbreak risk to public is 'absolutely low', WHO says France 24 1d Tenerife WHO Hantavirus All sources
Angelini Pharma to acquire Catalyst Pharmaceuticals for equity value of $4.1bn Pharmaceutical Technology 1d Angelini Pharma Catalyst Pharmaceuticals Business (US) All sources
myTomorrows partners with Rare Disease Research to boost rare disease referrals PMLiVE 10:43 Thu, 30 Apr Global Health All sources
Mississippi Rare Disease task force comes as families travel out of state for care Mississippi Free Press 2d Family Mississippi
The placebo effect is real and scientists just mapped the brain circuit behind it ZME Science 1d Opioid Crisis Global Health Science
Hantavirus outbreak on cruise ship: India monitors situation, no cases on Indian soil The Times of India 1d Hantavirus Biotech India
